Alexander Sidelmann Christensen

PhD student, MD
Translatiotional type 2-diabetes Research

​Contact

E-mail: Alexander.sidelmann.christensen@regionh.dk
Phone: +45 61 67 16 62   

Research area

  • Monogenetic diabetes
  • Physical activity and Type 2 Diabetes

Current research

The effect of GIP and GLP-1 in combination with sulphonylurea on insulin and glucagon secretion in patients with Hepatocyte Nuclear Factor 1 alpha diabetes (HNF1A-diabetes/MODY3)

Aim: To investigate if there is an additive effect of combining GIP, GLP-1 and sulphonylurea on insulin and glucagon secretion in patients with HNF1A-diabetes.

Collaborators: Novo Nordisk Foundation for Metabolic Research, Faculty of Health and Sciences, University of Copenhagen

GLIMLINA-trial: A randomised, double-blinded crossover trial investigating glimepiride + linagliptin vs. glimepiride monotherapy in patients with HNF1A- diabetes

Aim: To show that glimepiride + linagliptin provides good glycaemic control with low risk of hypoglycaemia

Collaborators: Novo Nordisk Foundation for Metabolic Research, Faculty of Health and Sciences, University of Copenhagen, Medical Research Lab, Diabetes and Endocrine Diseases, University hospital of Aarhus

Golf and Type 2 Diabetes

Aim: To investigate if a golf course and a one year membership in a golf club may increase the physical activity level in inactive patients with Type 2 Diabetes.
Collaborators: Danish Golf Union




Responsible editor